Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference

Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors

(2018) Tobias Speck et al.   CLINICAL CANCER RESEARCH

Breast cancer immunotherapy using magnetised oncolytic viruses

(2018) H. AL-Janabi et al.   EUROPEAN JOURNAL OF CANCER

Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines

(2018) Rachel Myers et al.   International Journal of Nanomedicine

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

(2018) Frederick F. Lang et al.   JOURNAL OF CLINICAL ONCOLOGY

In situ biomolecule production by bacteria; a synthetic biology approach to medicine

(2018) Yensi Flores Bueso et al.   JOURNAL OF CONTROLLED RELEASE

Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses

(2018) Miguel Ángel Muñoz-Alía et al.   PLoS One

Intracellular antibody signalling is regulated by phosphorylation of the Fc receptor TRIM21

(2018) Claire Dickson et al.   eLife

Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus–Driven Production of a Bispecific T-cell Engager

(2018) Anna Wing et al.   Cancer Immunology Research

A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models

(2018) Kader Yagiz et al.   Molecular Therapy-Oncolytics

The development of a monolith-based purification process for Orthopoxvirus vaccinia virus Lister strain

(2017) David Vincent et al.   JOURNAL OF CHROMATOGRAPHY A

Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity

(2017) Kei Hiraoka et al.   NEURO-ONCOLOGY

Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model

(2017) Leah A. Mitchell et al.   NEURO-ONCOLOGY

Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents

(2017) Joshua Del Papa et al.   Viruses-Basel

STING-Dependent Signaling Underlies IL-10 Controlled Inflammatory Colitis

(2017) Jeonghyun Ahn et al.   Cell Reports

Treg Depletion Licenses T Cell–Driven HEV Neogenesis and Promotes Tumor Destruction

(2017) Emily J. Colbeck et al.   Cancer Immunology Research

Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy

(2017) Sebastian Felgner et al.   OncoImmunology

Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus-Mediated Oncolysis

(2017) Desislava Tsoneva et al.   Molecular Therapy-Oncolytics

Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor

(2017) Cameron L. Lilly et al.   Molecular Therapy-Oncolytics

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators

(2017) Arthur Dyer et al.   Molecular Therapy-Oncolytics

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

(2017) Rocio Garcia-Carbonero et al.   Journal for ImmunoTherapy of Cancer

Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials

(2017) Ibrahim Ragab Eissa et al.   Frontiers in Oncology

Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome

(2017) Sebastian Felgner et al.   Microbial Biotechnology

The Microbiota of Breast Tissue and Its Association with Breast Cancer

(2016) Camilla Urbaniak et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis

(2016) Tianli Xia et al.   CANCER RESEARCH

Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma

(2016) Michelle J. Wilkinson et al.   INTERNATIONAL JOURNAL OF CANCER

Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy

(2016) Xing Cheng et al.   JOURNAL OF VIROLOGY

64. Generation of Tumor Cells Resistant to Oncolysis Is Mediated Through Virus Induced APOBEC Expression

(2016) Karishma Rajani et al.   MOLECULAR THERAPY

Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus

(2016) Rachel Myers et al.   MOLECULAR THERAPY

Effect of adenoviral death protein on NIS-based iodine therapy and imaging for pancreatic cancer

(2016) Lisa Koodie et al.   PANCREATOLOGY

Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma

(2016) Timothy F. Cloughesy et al.   Science Translational Medicine

Biomimetic Salmonella: A Next-Generation Therapeutic Vector?

(2016) Sebastian Felgner et al.   TRENDS IN MICROBIOLOGY

CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses

(2016) Ming Yuan et al.   Viruses-Basel

Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis

(2016) Michelle J. Wilkinson et al.   Oncotarget

Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis

(2016) Tianli Xia et al.   Cell Reports

Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS

(2016) Lianwen Zhang et al.   Human Gene Therapy Clinical Development

Recombinant mumps virus as a cancer therapeutic agent

(2016) Arun Ammayappan et al.   Molecular Therapy-Oncolytics

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia

(2015) C Parrish et al.   LEUKEMIA

The evolutionary history of lethal metastatic prostate cancer

(2015) Gunes Gundem et al.   NATURE

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

(2015) Colin S Cooper et al.   NATURE GENETICS

Diverse roles of STING-dependent signaling on the development of cancer

(2015) J Ahn et al.   ONCOGENE

Ultrasound-Propelled Nanocups for Drug Delivery

(2015) James J. Kwan et al.   Small

Oncolytic parvoviruses: from basic virology to clinical applications

(2015) Antonio Marchini et al.   Virology Journal

TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus

(2015) Ruth E. Watkinson et al.   PLoS Pathogens

Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression

(2014) A. Rodriguez-Garcia et al.   CLINICAL CANCER RESEARCH

Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft

(2014) Gewen Tan et al.   INTERNATIONAL JOURNAL OF CANCER

Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy

(2014) Stephen J. Russell et al.   MAYO CLINIC PROCEEDINGS

Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus

(2014) Elizabeth Ilett et al.   MOLECULAR THERAPY

Engineering of Bacteria for the Visualization of Targeted Delivery of a Cytolytic Anticancer Agent

(2013) Sheng-Nan Jiang et al.   MOLECULAR THERAPY